Evolus (EOLS) Common Equity (2017 - 2026)

Evolus has reported Common Equity for 10 years, with the latest figure at -$28.8 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 335.81% year-over-year to -$28.8 million; the trailing twelve-month figure through Mar 2026 stood at -$28.8 million (down 335.81% YoY), and the FY2025 full-year result was -$23.1 million, down 518.44% from the prior year.
• Common Equity for Q1 2026 stood at -$28.8 million, down from -$23.1 million in the prior quarter.
• The five-year high for Common Equity was $67.2 million in Q1 2022, with the low at -$28.8 million in Q1 2026.
• Historically, Common Equity has averaged $3.8 million across 5 years, with a median of $5.5 million in 2024.
• Annual changes were most pronounced in 2024 — Common Equity surged 377.38% — and 2025, when it sank 588.29%.
• Evolus' Common Equity stood at $18.5 million in 2022, then slumped by 211.84% to -$20.7 million in 2023, then soared by 126.69% to $5.5 million in 2024, then sank by 518.44% to -$23.1 million in 2025, then decreased by 24.56% to -$28.8 million in 2026.
• The last three Common Equity figures came in at -$28.8 million (Q1 2026), -$23.1 million (Q4 2025), and -$28.8 million (Q3 2025), per Business Quant data.